Alterity therapeutics announces multiple oral and poster presentations to be featured at the international msa congress

Melbourne, australia and san francisco, may 07, 2025 (globe newswire) -- alterity therapeutics (asx: ath, nasdaq: athe) (“alterity” or “the company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that multiple oral and poster presentations related to alterity's clinical programs in multiple system atrophy (msa) will be featured at the 2025 international msa congress taking place may 9 - 11, 2025 in boston, ma, usa. the congress is presented by mission msa, a non-profit organization dedicated to improving the quality of life and building hope for people affected by msa through support services, educational resources, research funding, and community engagement.
MSA Ratings Summary
MSA Quant Ranking